Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

PDF

Physician Assistant Scholarly Project Posters

ADHD

Publication Year

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

Mood Stabilizers Vs Stimulants For The Management Of Attention-Deficit/Hyperactivity Disorder And Comorbidity Bipolar Disorder, Karina Van Slyke Apr 2024

Mood Stabilizers Vs Stimulants For The Management Of Attention-Deficit/Hyperactivity Disorder And Comorbidity Bipolar Disorder, Karina Van Slyke

Physician Assistant Scholarly Project Posters

BD and ADHD share a lot of similar symptoms such as comorbidities, age of onset, chronic, enduring course of illness with interference of vocational, educational, and developmental milestones. There is immense challenge when it comes to differentiating these disorders due to significant overlap and variable courses of psychopathology in children. Providers need to be aware of the medications that are beneficial for each condition separately and which medications can benefit both conditions. Mood stabilizers are commonly used in bipolar disorder while stimulants are a common treatment for ADHD. A literature review was performed using search databases such as PubMed to …


Pharmacotherapy For Impulsivity-Hyperactivity Behaviors In Autism Spectrum Disorder, Jenna Katnis Jan 2019

Pharmacotherapy For Impulsivity-Hyperactivity Behaviors In Autism Spectrum Disorder, Jenna Katnis

Physician Assistant Scholarly Project Posters

Hyperactivity is a shared behavior with ASD and Attention Deficit Hyperactivity Disorder (ADHD). Medications such as Methylphenidate (MPH) and α 2-a adrenergic receptor agonists are used to modify hyperactivity behavior in ADHD and thus have been used as management in ASD. A review of literature was done to evaluate the use of medications typically used for ADHD in the use of ASD. The databases searched included PubMED, PsycINFO, Cochrane, and Clinical Key. After reviewing the literature, it was found that both MPH and 2-a adrenergic receptor agonist have a potential role in pharmacotherapy for ASD. MPH may be slightly more …